A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome

OBJECTIVE: This study was undertaken to evaluate efficacy and long‐term safety of triheptanoin in patients >1 year old, not on a ketogenic diet, with drug‐resistant seizures associated with glucose transporter 1 deficiency syndrome (Glut1DS). METHODS: UX007G‐CL201 was a randomized, double‐blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Striano, Pasquale, Auvin, Stéphane, Collins, Abigail, Horvath, Rita, Scheffer, Ingrid E., Tzadok, Michal, Miller, Ian, Kay Koenig, Mary, Lacy, Adrian, Davis, Ronald, Garcia‐Cazorla, Angela, Saneto, Russell P., Brandabur, Melanie, Blair, Susan, Koutsoukos, Tony, De Vivo, Darryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546029/
https://www.ncbi.nlm.nih.gov/pubmed/35441706
http://dx.doi.org/10.1111/epi.17263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546029/
https://www.ncbi.nlm.nih.gov/pubmed/35441706
http://dx.doi.org/10.1111/epi.17263

Ejemplares similares